杆菌被判犯有阻塞性黄:儿童病例报告
Parker Giroux1, Andrew Palmer2, Aby Thomas2
1From the Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's of Mississippi, University of Mississippi Medical Center, Jackson, MS.
JPGN reports
|November 30, 2023
概括
一个罕见的儿科Helicobacter pylori感染病例呈现出由于十二指肠引起的阻塞性黄. 这突显了儿童中H. pylori罕见的并发症.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 传染性疾病 传染性疾病
- 肝病学 肝病学是一种肝病学.
背景情况:
- 在全球范围内,小儿Helicobacter pylori (H. pylori) 感染率正在下降.
- 典型的H. pylori在儿童中的表现记录得很好.
- 十二指甲腺是已知H. pylori感染的并发症.
研究的目的:
- 报告一例罕见的阻塞性黄病例,该病例发生在一名儿科患者身上,该病例是由H. pylori诱导的十二指肠引起的.
- 审查H. pylori感染及其并发症.
- 为了强调阻塞性黄在儿科十二指肠中不经常出现的情况.
主要方法:
- 一个15岁男孩的案例报告.
- 临床表现包括黄,贫血,黑色尿液和腹痛.
- 阻塞性黄和十二指肠的诊断工作.
- 关于H. pylori并发症的文献综述.
主要成果:
- 患者出现了暗示阻塞性黄的症状.
- 一个H. pylori感染被确定为十二指肠的原因.
- 十二指肠导致了阻塞性黄,这是这个年龄组罕见的并发症.
结论:
- 阻塞性黄是儿科十二指肠的一个非常罕见的并发症.
- 在患有异常胃肠道和肝胆道症状的儿科患者中,应考虑感染H. pylori.
- 这一案例强调了识别H. pylori感染的各种临床表现的重要性.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
131
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
131
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
411
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
411
Peptic Ulcer Disease I: Introduction
178
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
178
Diseases of the Liver and Gallbladder
560
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
560
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
435
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
435
Gastritis III: Clinical Manifestations and Management
274
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
274


